Evaluation of Parapapillary Choroidal Microvasculature Dropout and Progressive Retinal Nerve Fiber Layer Thinning in Patients With Glaucoma.
Adult
Aged
Aged, 80 and over
Choroid
/ blood supply
Choroid Diseases
/ diagnosis
Ciliary Arteries
/ pathology
Disease Progression
Female
Fluorescein Angiography
Follow-Up Studies
Glaucoma, Open-Angle
/ diagnosis
Humans
Intraocular Pressure
Male
Middle Aged
Nerve Fibers
/ pathology
Optic Disk
Prospective Studies
Retinal Ganglion Cells
/ pathology
Tomography, Optical Coherence
/ methods
Visual Fields
Young Adult
Journal
JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539
Informations de publication
Date de publication:
01 07 2019
01 07 2019
Historique:
pubmed:
24
5
2019
medline:
23
2
2020
entrez:
24
5
2019
Statut:
ppublish
Résumé
Parapapillary choroidal microvasculature dropout (MvD) is considered one of pathophysiological manifestations of glaucomatous damage. To evaluate the longitudinal change in the parapapillary choroidal MvD in patients with primary open-angle glaucoma (POAG), and to determine whether this change is associated with progressive retinal nerve fiber layer (RNFL) thinning. This prospective observational case series was conducted at a tertiary referral center in Korea and included 68 patients with POAG who exhibited parapapillary choroidal MvD in en face optical coherence tomography (OCT) angiography (OCTA) images who were enrolled from the ongoing Investigating Glaucoma Progression Study from January 1, 2016, through July 31, 2018. The mean (SD) follow-up period was 2.5 (0.2) years and observers were masked to the clinical characteristics of the participants for measurements. The OCTA images were obtained twice at an interval of at least 2 years, during which the RNFL thickness was measured at least 4 times in serial OCT examinations. Microvasculature dropout was defined as a focal sectoral capillary dropout with no visible microvascular network identified in the choroidal layer. The MvD area was measured in the OCTA images obtained at the baseline and the final follow-up. The significance of changes in the MvD area was defined using the 95% Bland-Altman limits of agreement. The rate of RNFL thinning was determined by linear regression of the serial OCT RNFL thickness measurements. The association between the change in the MvD area and the rate of RNFL thinning. Of 68 Korean participants, 37 (54.5%) were women, and the mean (SD) age was 54.3 (13.1) years. Among 68 eyes, 22 (32.4%) showed increases in the MvD area during the follow-up. Faster global RNFL thinning was associated with a larger baseline parapapillary atrophy β-zone (β = -0.55; 95% CI, -0.96 to -0.14; P = .01), disc hemorrhage detection during the follow-up period (β = -0.75; 95% CI, -1.67 to -0.34; P = .001), and a larger increase in the MvD area (β = -4.74; 95% CI, -7.72 to -1.75; P = .002). The MvD area was not associated with the rate of RNFL thinning at baseline or the final follow-up. Microvasculature dropout enlargement was associated with progressive RNFL thinning in POAG.
Identifiants
pubmed: 31120486
pii: 2734136
doi: 10.1001/jamaophthalmol.2019.1212
pmc: PMC6547096
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
810-816Références
J Glaucoma. 2018 Feb;27(2):189-196
pubmed: 29271810
Ophthalmology. 2014 Jul;121(7):1322-32
pubmed: 24629312
Am J Ophthalmol. 2000 Nov;130(5):589-96
pubmed: 11078837
Ophthalmology. 2015 Apr;122(4):721-9
pubmed: 25433610
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):217-22
pubmed: 19684001
Am J Ophthalmol. 2018 Apr;188:141-154
pubmed: 29428454
Ophthalmology. 2014 Jul;121(7):1341-9
pubmed: 24565742
Br J Ophthalmol. 1996 Sep;80(9):812-7
pubmed: 8942378
Ophthalmology. 2016 Dec;123(12):2509-2518
pubmed: 27769587
Opt Express. 2012 Feb 13;20(4):4710-25
pubmed: 22418228
J Glaucoma. 2013 Sep;22(7):532-41
pubmed: 22549477
J Glaucoma. 2017 Apr;26(4):e142-e145
pubmed: 27599177
Invest Ophthalmol Vis Sci. 2006 May;47(5):2006-10
pubmed: 16639009
Acta Ophthalmol Scand. 2004 Aug;82(4):426-31
pubmed: 15291936
Ophthalmology. 2008 May;115(5):904-10
pubmed: 17870170
Ophthalmology. 2018 Apr;125(4):588-596
pubmed: 29224927
Am J Ophthalmol. 1998 Oct;126(4):487-97
pubmed: 9780093
Am J Ophthalmol. 2000 Oct;130(4):429-40
pubmed: 11024415
Ophthalmology. 2017 Aug;124(8):1209-1217
pubmed: 28433445
Invest Ophthalmol Vis Sci. 2013 Nov 21;54(12):7699-706
pubmed: 24130177
Ophthalmology. 2018 Jul;125(7):1003-1013
pubmed: 29486903
Am J Ophthalmol. 2016 Aug;168:237-249
pubmed: 27296492
Curr Eye Res. 2016 Nov;41(11):1447-1453
pubmed: 27159148
Arch Ophthalmol. 2003 Jan;121(1):48-56
pubmed: 12523884
Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1675-81
pubmed: 19029038
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1621-1627
pubmed: 28297027
J Glaucoma. 2011 Oct;20(8):470-6
pubmed: 20852437
Am J Ophthalmol. 1998 Oct;126(4):498-505
pubmed: 9780094
Arch Ophthalmol. 1979 May;97(5):948-50
pubmed: 109068
Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3004-3010
pubmed: 28605811
Ophthalmology. 2011 Sep;118(9):1782-9
pubmed: 21665283
Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
pubmed: 12049574
Acta Ophthalmol Suppl. 1971;111:3-83
pubmed: 4335893